[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DNA Sequencer-Global Market Status and Trend Report 2013-2023

May 2018 | 148 pages | ID: D95979CDA19MEN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

DNA Sequencer-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on DNA Sequencer industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of DNA Sequencer 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of DNA Sequencer worldwide, with company and product introduction, position in the DNA Sequencer market
Market status and development trend of DNA Sequencer by types and applications
Cost and profit status of DNA Sequencer, and marketing status
Market growth drivers and challenges

The report segments the global DNA Sequencer market as:

Global DNA Sequencer Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global DNA Sequencer Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Emulsion PCR
Bridge Amplification
Single-molecule
PCR

Global DNA Sequencer Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Molecular Biology
Evolutionary Biology
Metagenomics
Medicine
Others

Global DNA Sequencer Market: Manufacturers Segment Analysis (Company and Product introduction, DNA Sequencer Sales Volume, Revenue, Price and Gross Margin):

Roche
Illumina
Life Technologies
Beckman Coulter
Pacific Biosciences
Oxford Nanopore
Abbott Laboratories
GE Healthcare Life Sciences
Johnson & Johnson

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DNA SEQUENCER

1.1 Definition of DNA Sequencer in This Report
1.2 Commercial Types of DNA Sequencer
  1.2.1 Emulsion PCR
  1.2.2 Bridge Amplification
  1.2.3 Single-molecule
  1.2.4 PCR
1.3 Downstream Application of DNA Sequencer
  1.3.1 Molecular Biology
  1.3.2 Evolutionary Biology
  1.3.3 Metagenomics
  1.3.4 Medicine
  1.3.5 Others
1.4 Development History of DNA Sequencer
1.5 Market Status and Trend of DNA Sequencer 2013-2023
  1.5.1 Global DNA Sequencer Market Status and Trend 2013-2023
  1.5.2 Regional DNA Sequencer Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of DNA Sequencer 2013-2017
2.2 Sales Market of DNA Sequencer by Regions
  2.2.1 Sales Volume of DNA Sequencer by Regions
  2.2.2 Sales Value of DNA Sequencer by Regions
2.3 Production Market of DNA Sequencer by Regions
2.4 Global Market Forecast of DNA Sequencer 2018-2023
  2.4.1 Global Market Forecast of DNA Sequencer 2018-2023
  2.4.2 Market Forecast of DNA Sequencer by Regions 2018-2023

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of DNA Sequencer by Types
3.2 Sales Value of DNA Sequencer by Types
3.3 Market Forecast of DNA Sequencer by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of DNA Sequencer by Downstream Industry
4.2 Global Market Forecast of DNA Sequencer by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America DNA Sequencer Market Status by Countries
  5.1.1 North America DNA Sequencer Sales by Countries (2013-2017)
  5.1.2 North America DNA Sequencer Revenue by Countries (2013-2017)
  5.1.3 United States DNA Sequencer Market Status (2013-2017)
  5.1.4 Canada DNA Sequencer Market Status (2013-2017)
  5.1.5 Mexico DNA Sequencer Market Status (2013-2017)
5.2 North America DNA Sequencer Market Status by Manufacturers
5.3 North America DNA Sequencer Market Status by Type (2013-2017)
  5.3.1 North America DNA Sequencer Sales by Type (2013-2017)
  5.3.2 North America DNA Sequencer Revenue by Type (2013-2017)
5.4 North America DNA Sequencer Market Status by Downstream Industry (2013-2017)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe DNA Sequencer Market Status by Countries
  6.1.1 Europe DNA Sequencer Sales by Countries (2013-2017)
  6.1.2 Europe DNA Sequencer Revenue by Countries (2013-2017)
  6.1.3 Germany DNA Sequencer Market Status (2013-2017)
  6.1.4 UK DNA Sequencer Market Status (2013-2017)
  6.1.5 France DNA Sequencer Market Status (2013-2017)
  6.1.6 Italy DNA Sequencer Market Status (2013-2017)
  6.1.7 Russia DNA Sequencer Market Status (2013-2017)
  6.1.8 Spain DNA Sequencer Market Status (2013-2017)
  6.1.9 Benelux DNA Sequencer Market Status (2013-2017)
6.2 Europe DNA Sequencer Market Status by Manufacturers
6.3 Europe DNA Sequencer Market Status by Type (2013-2017)
  6.3.1 Europe DNA Sequencer Sales by Type (2013-2017)
  6.3.2 Europe DNA Sequencer Revenue by Type (2013-2017)
6.4 Europe DNA Sequencer Market Status by Downstream Industry (2013-2017)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific DNA Sequencer Market Status by Countries
  7.1.1 Asia Pacific DNA Sequencer Sales by Countries (2013-2017)
  7.1.2 Asia Pacific DNA Sequencer Revenue by Countries (2013-2017)
  7.1.3 China DNA Sequencer Market Status (2013-2017)
  7.1.4 Japan DNA Sequencer Market Status (2013-2017)
  7.1.5 India DNA Sequencer Market Status (2013-2017)
  7.1.6 Southeast Asia DNA Sequencer Market Status (2013-2017)
  7.1.7 Australia DNA Sequencer Market Status (2013-2017)
7.2 Asia Pacific DNA Sequencer Market Status by Manufacturers
7.3 Asia Pacific DNA Sequencer Market Status by Type (2013-2017)
  7.3.1 Asia Pacific DNA Sequencer Sales by Type (2013-2017)
  7.3.2 Asia Pacific DNA Sequencer Revenue by Type (2013-2017)
7.4 Asia Pacific DNA Sequencer Market Status by Downstream Industry (2013-2017)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America DNA Sequencer Market Status by Countries
  8.1.1 Latin America DNA Sequencer Sales by Countries (2013-2017)
  8.1.2 Latin America DNA Sequencer Revenue by Countries (2013-2017)
  8.1.3 Brazil DNA Sequencer Market Status (2013-2017)
  8.1.4 Argentina DNA Sequencer Market Status (2013-2017)
  8.1.5 Colombia DNA Sequencer Market Status (2013-2017)
8.2 Latin America DNA Sequencer Market Status by Manufacturers
8.3 Latin America DNA Sequencer Market Status by Type (2013-2017)
  8.3.1 Latin America DNA Sequencer Sales by Type (2013-2017)
  8.3.2 Latin America DNA Sequencer Revenue by Type (2013-2017)
8.4 Latin America DNA Sequencer Market Status by Downstream Industry (2013-2017)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa DNA Sequencer Market Status by Countries
  9.1.1 Middle East and Africa DNA Sequencer Sales by Countries (2013-2017)
  9.1.2 Middle East and Africa DNA Sequencer Revenue by Countries (2013-2017)
  9.1.3 Middle East DNA Sequencer Market Status (2013-2017)
  9.1.4 Africa DNA Sequencer Market Status (2013-2017)
9.2 Middle East and Africa DNA Sequencer Market Status by Manufacturers
9.3 Middle East and Africa DNA Sequencer Market Status by Type (2013-2017)
  9.3.1 Middle East and Africa DNA Sequencer Sales by Type (2013-2017)
  9.3.2 Middle East and Africa DNA Sequencer Revenue by Type (2013-2017)
9.4 Middle East and Africa DNA Sequencer Market Status by Downstream Industry (2013-2017)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DNA SEQUENCER

10.1 Global Economy Situation and Trend Overview
10.2 DNA Sequencer Downstream Industry Situation and Trend Overview

CHAPTER 11 DNA SEQUENCER MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of DNA Sequencer by Major Manufacturers
11.2 Production Value of DNA Sequencer by Major Manufacturers
11.3 Basic Information of DNA Sequencer by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of DNA Sequencer Major Manufacturer
  11.3.2 Employees and Revenue Level of DNA Sequencer Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 DNA SEQUENCER MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 Roche
  12.1.1 Company profile
  12.1.2 Representative DNA Sequencer Product
  12.1.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Roche
12.2 Illumina
  12.2.1 Company profile
  12.2.2 Representative DNA Sequencer Product
  12.2.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Illumina
12.3 Life Technologies
  12.3.1 Company profile
  12.3.2 Representative DNA Sequencer Product
  12.3.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Life Technologies
12.4 Beckman Coulter
  12.4.1 Company profile
  12.4.2 Representative DNA Sequencer Product
  12.4.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Beckman Coulter
12.5 Pacific Biosciences
  12.5.1 Company profile
  12.5.2 Representative DNA Sequencer Product
  12.5.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Pacific Biosciences
12.6 Oxford Nanopore
  12.6.1 Company profile
  12.6.2 Representative DNA Sequencer Product
  12.6.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Oxford Nanopore
12.7 Abbott Laboratories
  12.7.1 Company profile
  12.7.2 Representative DNA Sequencer Product
  12.7.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.8 GE Healthcare Life Sciences
  12.8.1 Company profile
  12.8.2 Representative DNA Sequencer Product
  12.8.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of GE Healthcare Life Sciences
12.9 Johnson & Johnson
  12.9.1 Company profile
  12.9.2 Representative DNA Sequencer Product
  12.9.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Johnson & Johnson

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DNA SEQUENCER

13.1 Industry Chain of DNA Sequencer
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DNA SEQUENCER

14.1 Cost Structure Analysis of DNA Sequencer
14.2 Raw Materials Cost Analysis of DNA Sequencer
14.3 Labor Cost Analysis of DNA Sequencer
14.4 Manufacturing Expenses Analysis of DNA Sequencer

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications